DE3785615T2 - Hemmungsstoffe der serin-protease. - Google Patents

Hemmungsstoffe der serin-protease.

Info

Publication number
DE3785615T2
DE3785615T2 DE8787870078T DE3785615T DE3785615T2 DE 3785615 T2 DE3785615 T2 DE 3785615T2 DE 8787870078 T DE8787870078 T DE 8787870078T DE 3785615 T DE3785615 T DE 3785615T DE 3785615 T2 DE3785615 T2 DE 3785615T2
Authority
DE
Germany
Prior art keywords
protease inhibitors
serin protease
serin
inhibitors
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787870078T
Other languages
English (en)
Other versions
DE3785615D1 (de
Inventor
George Irvin Glover
Charles Allan Mcwherter
Charles Steven Schasteen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DE3785615D1 publication Critical patent/DE3785615D1/de
Application granted granted Critical
Publication of DE3785615T2 publication Critical patent/DE3785615T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8787870078T 1986-06-11 1987-06-10 Hemmungsstoffe der serin-protease. Expired - Fee Related DE3785615T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87301486A 1986-06-11 1986-06-11
US07/045,833 US4829052A (en) 1986-06-11 1987-05-08 Serine protease inhibitors

Publications (2)

Publication Number Publication Date
DE3785615D1 DE3785615D1 (de) 1993-06-03
DE3785615T2 true DE3785615T2 (de) 1993-08-05

Family

ID=26723250

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787870078T Expired - Fee Related DE3785615T2 (de) 1986-06-11 1987-06-10 Hemmungsstoffe der serin-protease.

Country Status (6)

Country Link
US (1) US4829052A (de)
EP (1) EP0252057B1 (de)
JP (1) JP2520131B2 (de)
CA (1) CA1308864C (de)
DE (1) DE3785615T2 (de)
ES (1) ES2053588T3 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
FR2647677B1 (fr) * 1989-05-31 1991-09-27 Roussel Uclaf Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
US7413537B2 (en) * 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat
WO1992006191A1 (en) * 1990-09-28 1992-04-16 Protein Engineering Corporation Proteinaceous anti-dental plaque agents
US20040087498A1 (en) * 1991-02-28 2004-05-06 Novo Nordisk Health Care Ag Modified factor VII
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
US5997864A (en) * 1995-06-07 1999-12-07 Novo Nordisk A/S Modified factor VII
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
US5817788A (en) * 1991-02-28 1998-10-06 Zymogenetics, Inc. Modified factor VII
US5861374A (en) * 1991-02-28 1999-01-19 Novo Nordisk A/S Modified Factor VII
JP4146512B2 (ja) * 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
US6039944A (en) * 1992-02-28 2000-03-21 Zymogenetics, Inc. Modified Factor VII
US6869925B1 (en) 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
GB2318732A (en) * 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US6489308B1 (en) 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
AU3864000A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
PT1402073E (pt) * 2001-06-05 2007-05-31 Auckland Uniservices Ltd Métodos e composições para avaliação da função e distúrbios pulmonares.
US20040018984A1 (en) * 2002-07-17 2004-01-29 Mizuo Miyazaki Methods for preventing adhesion formation using protease inhibitors
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
FR2870382A1 (fr) * 2004-05-13 2005-11-18 Commissariat Energie Atomique Cablage de connexion elastique
CA2608142A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
AU2006248201A1 (en) * 2005-05-19 2006-11-23 Synergenz Bioscience Limited Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
WO2012178102A2 (en) 2011-06-24 2012-12-27 The Regents Of The Unversity Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
BR112014003787A2 (pt) * 2011-08-23 2020-10-27 Synapse B.V. inibidores termoestáveis de ativação do sistema de coagulação sanguínea por contato com superfícies estranhas
JP2015504675A (ja) 2012-01-10 2015-02-16 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ アルファ−１アンチトリプシン融合分子の組成物、方法、及び使用

Also Published As

Publication number Publication date
EP0252057B1 (de) 1993-04-28
DE3785615D1 (de) 1993-06-03
EP0252057A2 (de) 1988-01-07
JPS6322027A (ja) 1988-01-29
CA1308864C (en) 1992-10-13
US4829052A (en) 1989-05-09
EP0252057A3 (en) 1989-08-23
ES2053588T3 (es) 1994-08-01
JP2520131B2 (ja) 1996-07-31

Similar Documents

Publication Publication Date Title
DE3785615T2 (de) Hemmungsstoffe der serin-protease.
DK674387D0 (da) Proteaseinhibitorer
FI843934A0 (fi) En fem-ledad heterocyklisk ring innehaollande n-(bicyklisheterocyklyl)-4-piperidinaminer.
ATE97652T1 (de) Peptidasehemmungsmittel.
NO863596D0 (no) Enbakteriell metionin n-terminal peptidase.
DE3750963T2 (de) Reflektometer.
MX9100119A (es) Inhibidores de proteasa retroviral
NO895026L (no) Retrovirale proteasehemmere.
DE3674131D1 (de) Substituierte dihalo-statin-reninhemmungsmittel.
MX9100120A (es) Inhibidores de proteasas retrovirales
FI862481A0 (fi) Aktiverat bergsskaerningsaggregat.
NO875199L (no) Renin-inhibitorer.
NO864337D0 (no) Dopamin-beta-hydrolase-inhibitorer.
DE68922014T2 (de) Protease.
NO875381D0 (no) Renininhibitorer.
FI850131A0 (fi) N-(naftylalkyl)-hydroxylaminer.
ATE88720T1 (de) Hemmungsstoffe der serin-protease.
NO872985L (no) Inhibitor for polyuretanpropergoler.
NO900081D0 (no) Proteaseinhibitorer.
MX22596A (es) Inhibidores de proteasas retrovirales.
DK479187D0 (da) Operationslagen til hovedoperationer
MX9203679A (es) Compuestos inhibidores de proteasa retroviral.
MX9203693A (es) Compuestos inhibidores de proteasa retroviral.
IS3397A7 (is) Ensím (gerhvati) hindri (inhibitors) (Protease Inhibitors)
NO873250D0 (no) Piggdekk.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee